On November 4, Universal Health posted an Intraday Rise of 5.62% in Regular Trading, trading at $189.99, with turnover of $6.40 million.
The most recent disclosed catalyst was a Wells Fargo price target increase to $170 from $166, published on November 2, following the company’s late-October third-quarter report that modestly exceeded consensus on revenue and adjusted earnings.
In that quarterly update, Universal Health reported adjusted EPS of $5.22 on revenue of $4.73 billion, compared with market expectations of about $5.16 to $5.19 per share and $4.71 billion to $4.712 billion in revenue. However, adjusted earnings were down from $5.69 a year earlier. Separately, another analyst noted third-quarter adjusted EBITDA missed estimates because stronger volumes were offset by weaker pricing and margin pressure, and cut its target price to $170. The latest share rise appears aligned with post-earnings sentiment repair as investors weigh the earnings beat against ongoing profitability concerns.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments